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Deubiquitinating enzymes (DUBs) regulate ubiquitin signaling by trimming ubiquitin chains or
removing ubiquitin from modified substrates. Similar activities exist for ubiquitin-related
modifiers, although the enzymes involved are usually not related. Here, we report human
ZUFSP (also known as ZUP1 and C6orf113) and fission yeast Mug105 as founding members of
a DUB family different from the six known DUB classes. The crystal structure of human
ZUFSP in covalent complex with propargylated ubiquitin shows that the DUB family shares a
fold with UFM1- and Atg8-specific proteases, but uses a different active site more similar to
canonical DUB enzymes. ZUFSP family members differ widely in linkage specificity through
differential use of modular ubiquitin-binding domains (UBDs). While the minimalistic
Mug105 prefers K48 chains, ZUFSP uses multiple UBDs for its K63-specific endo-DUB
activity. K63 specificity, localization, and protein interaction network suggest a role for ZUFSP
in DNA damage response.
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The covalent attachment of ubiquitin to proteins via the ε-amino group of substrate lysine residues is—besidesphosphorylation—the most important posttranslational
modification for regulating protein signaling and homeostasis1.
The ability of ubiquitin to target other ubiquitin molecules at
various lysine residues, giving rise to ubiquitin chains of different
linkage types, contributes substantially to the versatility of the
ubiquitination system2. Deubiquitinating enzymes (DUBs) are
isopeptidases that can deconjugate single ubiquitin units or entire
ubiquitin chains from proteins, thereby erasing or modulating the
ubiquitin signal. In addition, several DUBs are also able to cleave
peptide bonds at the C terminus of ubiquitin, an activity required
for processing the primary translation products of the ubiquitin
genes and thus essential for the entire ubiquitination cascade. The
human genome encodes approximately 100 DUB enzymes
belonging to 6 different families, which exhibit distinct but
overlapping cleavage preferences3,4. Five of these families are
cysteine proteases, some of which show weak but significant
sequence similarity to each other5. The sixth family belongs to the
metalloproteases and appears to be evolutionary more ancient,
since it contains bacterial and archaeal members that are likely to
act on prokaryotic ubiquitin-fold proteins6. Besides ubiquitin,
there are several ubiquitin-like modifiers (UBLs), which also
require proteases for processing their immature precursors and/
or for their deconjugation. Despite their mechanistic similarities,
UBL proteases typically belong to families distinct from DUBs7:
SUMO and NEDD8 are cleaved by members of the SENP/ULP
family, UFM1 is cleaved by the UFSP family, while the autophagy
modifiers ATG8 and ATG12 are cleaved by members of the
autophagin (ATG4) family8,9. Besides their catalytic domains,
many DUBs and UBL proteases harbor domains or motifs for
recognizing the modifier to be cleaved, or the substrate from
which the modifier is removed. This trend is particularly pro-
nounced for DUBs, where the presence of multiple ubiquitin-
binding domains (UBDs) can confer specificity for ubiquitin
chains of a particular linkage type10.
Here, we describe the biochemical and structural character-
ization of a seventh deubiquitinase family, which is distantly
related to proteases for ubiquitin-like modifiers, but has a dif-
ferent active site architecture and is truly specific for the cleavage
of ubiquitin. We provide a detailed analysis of ZUFSP (Zn-finger
and UFSP domain protein), the singular human member of this
family, which contains multiple UBDs responsible for the specific
action on K63-linked chains. By contrast, Mug105—a K48-
preferring ZUFSP homolog from the fission yeast Schizo-
saccharomyces pombe—lacks all UBDs and consists only of the
core catalytic domain. A comparison of ZUFSP and Mug105
offers unique insights into the mechanism of how the evolu-
tionary loss (or gain) of non-catalytic ubiquitin-binding domains
can profoundly change the specificity of a deubiquitinase.
Results
ZUFSP and Mug105 are related to UFM1/Atg8 proteases. The
catalytic domain of the UFM1-specific protease (UFSP) family
has been reported to be structurally related to that of the ATG4
family, enzymes that process the autophagy modifiers Atg8 and
Atg1211. By performing sensitive sequence analysis using the
generalized profile method12, we found this structural similarity
to be mirrored by a distant but highly significant sequence rela-
tionship (p < 0.001) between these families. Concurrently, a third
protein family containing the uncharacterized human protein
C6orf113/ZUFSP was found to exhibit significant sequence
similarity (p < 0.001) to both UFSP and ATG4 families of cysteine
proteases. As shown in Fig. 1a, the active site Cys and Asp resi-
dues of UFSP and ATG4 are conserved in members of the ZUFSP
family, while the catalytic His is absent. Hypothesizing that
ZUFSP might nevertheless be an active protease with a
rearranged active site, we analyzed ZUFSP family members from
a wide range of species and identified two highly conserved
histidine residues, with His-491 being the best candidate for
completing the active site of human ZUFSP (Supplementary































Fig. 1 ZUFSP and Mug105 are related to UFM1/Atg8 proteases. a Structurally correct alignment of the catalytic domains of human ZUFSP (this work),
mouse UFSP2 (3OQC) and human ATG4A (2P82). The S. pombe Mug105 sequence was added by sequence similarity to ZUFSP. Invariant and
conservatively replaced residues are shown on black or gray background, respectively. Catalytic residues are highlighted in blue. b Conservation of the four
UBZ-like zinc fingers of ZUFSP, in comparison to the structurally characterized UBZ finger (3WUP). c Conservation of the MIU domain of ZUFSP, in
comparison to other human MIU domains
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Fig. 2 ZUFSP and Mug105 are ubiquitin-specific proteases with different chain specificity. a Activity assays with Ub-/UbL-AMC substrates shown as
released fluorescence (RFU) over time (min) with ZUFSP or Mug105. Shown RFU values are the means of triplicates. b Fluorescent scan of a suicide probe
reaction of ZUFSP or Ufsp2 with Cy5-Ub-PA (arrow) and Rho-Ufm1-PA (arrowhead). Asterisks (*) mark the shifted band after reaction. c Suicide probe
reaction of ZUFSP or ATG4B with Ub-PA and LC3B-PA. Asterisks (*) mark the shifted band after reaction. d, e Linkage specificity analysis with ZUFSP. A
panel of di-ubiquitin (d) or tetra-ubiquitin (e) chains was treated with ZUFSP for the indicated time points. f Time course of cleavage of K63-linked Ub6+
chains by full-length ZUFSP. g Linkage specificity analysis with Mug105. A panel of Ub2 was treated with Mug105 for the indicated time points. h Suicide
probe reaction with Mug105 and K48-diUb-VME, K63-diUb-VME or Ub-PA. Arrows mark the shifted bands after reaction
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members of the ZUFSP family, there are substantial differences in
the non-catalytic regions. Some members, including Mug105
from the fission yeast S. pombe, consist solely of the catalytic
domain, while most members contain one or more sequence
regions with significant similarity to known ubiquitin-binding
domains. Human ZUFSP contains four predicted C2H2 zinc
fingers related to the ubiquitin-binding UBZ-class13, followed by
a predicted MIU (motif interacting with ubiquitin) region14
(Fig. 1b, c). Thus, bioinformatical sequence analysis suggests that
ZUFSP could be an active protease that is distantly related to
various UBL-specific proteases, but has the potential to bind—
and maybe cleave—polyubiquitin chains.
ZUFSP and Mug105 are DUBs. Since ZUFSP is related to UBL
proteases and contains putative ubiquitin-binding domains, we
tested bacterially expressed ZUFSP proteins for catalytic activity
against ubiquitin and ubiquitin-related modifiers. Both human
ZUFSP and the S. pombe homolog Mug105 were able to liberate
the fluorophore AMC (7-amino-4-methylcoumarin) from a
ubiquitin-AMC fusion, indicating a cleavage after the C-terminal
Gly-76 of ubiquitin (Fig. 2a). The specific activities of ZUFSP and
Mug105 against this substrate were 2.3 and 4.1 nmol substrate per
mg enzyme per second, respectively (Supplementary Fig. 2a). By
contrast, analogous AMC fusions of the ubiquitin-like modifiers
SUMO1, SUMO2, NEDD8, ISG15 or LC3A were not processed
(Fig. 2a). Surprisingly, both ZUFSP and Mug105 were highly active
against RLRGG-AMC, a fusion of AMC, to a pentapeptide derived
from the ubiquitin C terminus (Fig. 2a). This reaction follows the
Michaelis–Menten kinetics with KM= 50.4 μM, kcat= 4.9 s−1 for
ZUFSP, and KM= 12.2 μM, kcat= 7.2 s−1 for Mug105 (Supple-
mentary Fig. 2b). The RLRGG-AMC peptide is not cleaved by
typical DUBs, which require an intact ubiquitin moiety for activity,
as shown here for USP21 (Supplementary Fig. 2c). While bacte-
rially expressed ZUFSP did not react with C-terminally pro-
pargylated UFM1 (UFM1-PA, Fig. 2b) or the propargylated Atg8
homolog LC3B-PA (Fig. 2c), it readily reacted with propargylated
ubiquitin (Ub-PA, Fig. 2b, c). Ub-PA is a covalent inhibitor that is
highly selective for thiol DUBs15; the analogous inhibitor UFM1-
PA reacts only with UFM1 proteases such as UFSP2, while LC3B-
PA reacts with Atg8 proteases such as ATG4B (Fig. 2b, c).
When tested against a panel of di-ubiquitin species of different
linkage types, ZUFSP showed a moderate activity towards K63-
linked di-ubiquitin, with some minimal activity towards K11- and
K48-linked species (Fig. 2d). When using tetra-ubiquitin sub-
strates, ZUFSP showed K63-specific cleavage with a markedly
increased activity: while K63-Ub4 was completely hydrolyzed after
30min (Fig. 2e), the hydrolysis of K63-Ub2 was not completed
after 6 h under comparable reaction conditions (Fig. 2d). This
preference for Ub4 over Ub2 suggests an ‘endo-cleavage’ mode for
ZUFSP, which became more evident when using longer K63-chain
substrates: while the upper bands disappear within the first
minutes, Ub2 is remarkably inert and mono-ubiquitin appears late
in the time course (Fig. 2f). The specificity for K63 cleavage is
maintained in ZUFSP truncations: gradual shortening of the N-
terminal region leads to decreased activity, but no change in the
linkage preference (Supplementary Fig. 3a-c).
Unlike the K63-specific ZUFSP, the compact homolog Mug105
from S. pombe cleaved K48-linked di-ubiquitin better than other
linkage types, with some residual activity against K63 and
K11 species (Fig. 2g). A concordant observation was made when
testing Mug105 with covalent DUB-specific inhibitors containing
a reactive group between two ubiquitin units16. Mug105 reacted
with the mono-ubiquitin-targeted probe Ub-PA and with the
K48-targeted probe K48-diUb-VME, but not with the corre-
sponding K63-targeted probe K63-diUb-VME (Fig. 2h). Thus,
both ZUFSP and Mug105 are linkage-specific DUBs, albeit with
different specificities. The multitude of predicted ubiquitin-
binding domains in ZUFSP, all absent from Mug105, might
account for the strikingly different chain preference.
ZUFSP and ATG4/UFSP structures differ in the active site. For
getting further insights into the unusual active site geometry of
ZUFSP and the basis for its K63 specificity, we solved the crystal
structure of a covalent complex between human ZUFSP (residues
232–578) and Ub-PA to a resolution of 1.7 Å (Table 1). The
asymmetric unit contains one ZUFSP ubiquitin conjugate, which
was almost completely resolved in the electron density. Only a
short flexible loop (AA: 468–473) and eight amino acids at the
very N terminus were not defined well enough in the electron
density to permit reliable modeling. The ZUFSP fragment used
for coupling to Ub-PA and subsequent crystallization starts
before the predicted MIU domain and encompasses the con-
served C-terminal region of human ZUFSP, including the cata-
lytic core domain and adjacent elements predicted to be
structured. The reaction product of thiol DUBs with Ub-PA
resembles an intermediate stage of the protease reaction, in which
the distal ubiquitin (poised for removal) occupies the S1 site of
the enzyme. The ZUFSP structure forms a globular α/β-folded
core with two prominent helical protrusions (Fig. 3a). The core
Table 1 Data collection and refinement statistics
ZUFSP S-SAD ZUFSP native
Data collection
Space group P6522 P6522
Unit cell constants
a, b, c (Å) 84.2, 84.2, 201.8 84.2, 84.2, 201.8
α; β; γ (°) 90, 90, 120 90, 90, 120
Wavelength (Å) 2.07 0.98
Resolution (Å) 59.13–2.3 (2.38–2.3) 49.45–1.73 (1.79–1.73)
No. of observations 4,098,044 (364,012) 484,411 (48,504)
No. of unique reflections 35,609 (3576)a 44,866 (4337)
Multiplicity 115.1 (101.8) 10.8 (11.2)
Completeness (%) 100 (100) 100 (99)
Rmerge (%) 11.7 (39.5) 8.4 (82.4)
Rmeas (%) 11.8 (39.7) 14.3 (86.4)
<I/σ(I)> 47.7 (13.9) 16.6 (2.5)

















Bond lengths (Å) 0.005
Bond angles (°) 0.6










aFriedel pairs were kept separate
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catalytic domain is clearly related to that of the UFM1-protease
UFSP2 (PDB: 3OQC)11; the two structures can be superimposed
with an RMS (root mean square deviation) distance of 3.65 Å
over 200 residues (Fig. 3b and Supplementary Fig. 4a). A long 29-
residue helix (α1) points away from the active site and provides
the S1 binding surface for the outgoing distal ubiquitin—here
occupied by the covalently coupled Ub-PA. The α2 and α3 helices
form a hairpin-like structure protruding from the catalytic core in
the opposite direction. This region has little contact with the
remainder of the structure and might form the S1’ site for binding
the proximal (substrate) ubiquitin. Of particular interest is the
organization of the active site (Fig. 3c). As expected from
sequence analysis, the positions of the catalytic Cys-360 (start of
α5) and Asp-512 (behind β5) are analogous to UFSPs and
ATG49,11. However, the catalytic His-491 of ZUFSP is provided
by the start of β4, whereas the catalytic histidine of UFSP and
ATG4 proteases would have been expected between β5 and α10.
In accordance with its catalytic role, His-491 is universally
conserved within the ZUFSP family (Supplementary Fig. 1),
and its essentiality for ZUFSP activity could be established
(Supplementary Fig. 2d). Through the use of a different catalytic
histidine, the active site geometry of ZUFSP resembles that of
papain17 and is almost a mirror image of the UFSP and ATG4
active sites (Fig. 3c). Both histidine positions appear equally
suited for acidifying the catalytic cysteine. Nevertheless, a fun-
damental change in active site architecture, as observed here
between the ZUFSP and UFSP families, is a rare event for evo-
lutionary related proteases that have maintained similar activities.
The oxyanion hole of ZUFSP has one remarkable difference to
other cysteine proteases with similar active site architecture. In
UFSPs and papain, the side chains of Tyr-282 and Gln-19
respectively provide polarized hydrogens for the electrophilic
pocket. Mutating these polar residues abolishes the proteolytic
activity11,18. In ZUFSP, the corresponding position is occupied by
Ser-351, which cannot act as hydrogen donor due to its smaller
side chain. Consequently, the S351A mutation showed no loss in
activity (Supplementary Fig. 5a, b). Attempts to improve the
catalytic rate by introducing more suitable side chains (S351Q or
S351Y) proved unsuccessful (Supplementary Fig. 5a, b), further
supporting the idea that the oxyanion hole in ZUFSP is different
from that in UFSPs and papain.
Contribution of the N terminus to ZUFSP catalytic activity.
While the crystal structure of ZUFSP in covalent complex with
ubiquitin offers interesting insights into the catalytic mechanism
and linkage specificity, the construct used for crystallization lacks
the predicted UBZ-like zinc fingers. Moreover, the MIU domain,
which forms the N-terminal part of the crystallized fragment, is
not contacting the distal S1 ubiquitin. For assessing the con-
tributions of the predicted UBDs to ZUFSP activity, a series of
truncation mutants were analyzed in a time course experiment
(Fig. 4a, b). When incubating full-length ZUFSP with long K63-
linked ubiquitin chains (Ub6+), most of the high-molecular-
weight material was reduced to Ub6 and shorter forms within 5
min, with very little mono-ubiquitin being generated. After 60
min, most of the substrate was present as di-ubiquitin, which—
being a poor ZUFSP substrate—required several hours for further
degradation. A ZUFSP construct starting at position 148, and
thus lacking the first two zinc fingers, was slightly more active
than full-length ZUFSP (Fig. 4b). By contrast, the construct used





















































Fig. 3 Crystal structure of ZUFSP232-578 in covalent complex with Ub-PA. a
Overview of the crystal structure in cartoon representation. The catalytic
core of ZUFSP is shown in gray, ubiquitin in blue. The MIU region on helix
α1 of ZUFSP is colored green, the zUBD region in cyan. The putative S1’
ubiquitin-binding α2/α3 helices are shown in red. The catalytic triad is
shown as sticks and colored orange. b Structural superposition of the
catalytic domain of ZUFSP (blue) and UFSP2 (3OQC, cyan) in two
perspectives. RMS distance is 3.65 Å over 200 residues. c Magnification of
the active site of ZUFSP (gray). The catalytic triad is colored orange,
putative components of the oxyanion hole in green and Trp-423, closing the
substrate binding groove directly next to the active site, is in dark pink.
Ubiquitin is shown in blue color. The active sites of Ufsp2 (cyan) and
papain (violet) are superimposed. Structurally equivalent residues of Ufsp2
and ZUFSP are shown as sticks. Important residues of ZUFSP (black), Ufsp2
(cyan) and papain (violet) are labeled. Important ubiquitin residue labels
contain asterisks. In the available structure (3OQC) of UFSP2, the catalytic
cysteine was mutated to a serine, indicated here as ‘S294
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domain, was substantially less active against K63 chains. Even
shorter versions, such as the one starting at position 249 after the
MIU, or starting at 274 after the α1 helix, were hardly active
against K63 chains (Fig. 4b). The same trend was observed when
testing the truncation mutants against Ub4 and Ub2 (Supple-
mentary Fig. 3d, e).
The shortest fragment tested for activity starts at position 310
and corresponds to the core catalytic domain, analogous to the
wild-type Mug105 protein. While both Mug105 and the human
core fragment were active against ubiquitin-AMC (Fig. 4c) and
thus properly folded, only Mug105 was able to cleave ubiquitin
chains (Fig. 4d). Thus, the surface features conferring K48 spe-
cificity to Mug105 are not conserved in the human core fragment.
The catalytic activity of the ZUFSP truncations is closely mirrored
by the ability of the corresponding proteins to bind ubiquitin
chains. In a pull-down experiment with immobilized His-tagged
ZUFSP truncations and K63-liked ubiquitin chains, only the full-
length protein and the truncation starting at 148 showed robust
ubiquitin-binding (Fig. 4e).
Determinants of ZUFSP specificity. Analysis of the contact
surface between ZUFSP and the covalently bound ubiquitin
revealed two major substrate recognition modalities. The inter-
face most critical for proteolytic activity is formed by salt bridges
involving two acidic residues of ZUFSP (Asp-406 and Glu-428)
and the two arginine residues within the C-terminal tail of ubi-
quitin (Arg-72 and Arg-74) (Fig. 5a). These side-chain interac-
tions position the ubiquitin C terminus next to the catalytic
cysteine and are thus absolutely crucial for the cleavage of ubi-
quitin chains and the model substrate RLRGG-AMC (Fig. 5b, c).
In both assays, mutation of either D406A or E428A renders
ZUFSP as inactive as the active site mutant C360A. This Arg–Arg
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Fig. 4 ZUFSP UBDs contribute to chain cleavage and specificity. a Schematic representation of ZUFSP domain architecture. UBZ-like zinc fingers (Z), MIU
domain (M), novel ZUFSP ubiquitin-binding domain (zUBD) and α2/α3 region are shown as boxes. b Activity of ZUFSP FL and truncations lacking the
UBDs against K63-linked Ub6+ chains. Positions of the truncated ZUFSP proteins are indicated by arrows. c Comparison of Mug105 and ZUFSP310-578
activity against ubiquitin-AMC. The shown RFU values are the mean of triplicates. d Chain specificity of ZUFSP catalytic core (ZUFSP310-578) compared to
full-length Mug105. Both DUBs were tested against K48- and K63-linked Ub2 for the indicated time points. e Pull-down analysis of ZUFSP (full-length and
two N-terminal truncations) against a mixture of K63-linked Ub4 and Ub5 chains
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before the Ser-360, defines the specificity of ZUFSP for the C
terminus of ubiquitin (RLRGG). The tunnel itself is formed by
the core of the cysteine peptidase as well as the side chains of
Tyr-267, Trp-423, Gln-489 and Gly-490. At least in the con-
formation found in our crystal structure, the space within the
tunnel only permits glycine to pass (Supplementary Fig. 4b). A
second interaction surface is formed by the second half of the
ZUFSP α1 helix, which binds the Ile-44 patch of the S1ubiquitin
in an orientation similar, but not identical to that of the Rabex-5
MIU domain (Fig. 5d). The ubiquitin-binding part of the α1 helix,
here denoted as zUBD (ZUFSP ubiquitin-binding domain),
contacts the Ile-44 patch of ubiquitin at an angle tilted by 20°
relative to the MIU orientation. There is also a substantial
difference in the sequence consensus (Fig. 5e), emphasizing
that—despite the similar binding mode–the zUBD is not just an
unusual MIU. Close contacts between the zUBD and ubiquitin
are formed by two acidic residues (Glu-256 and Glu-259)
(Fig. 5f), which differ in their importance for ubiquitin cleavage:
while the E259A mutant was hardly active against Ub4, the E256A
mutant showed only a modest reduction in activity (Fig. 5g). The
N-terminal half of the ZUFSP α1 helix is formed by its canonical
MIU domain, but is not bound to ubiquitin and only partially
resolved in the available structure. Nevertheless, the canonical
MIU is ideally positioned to bind a distal S2-ubiquitin K63-linked
to the outgoing S1 ubiquitin present in the structure. A double
mutant targeting the highly conserved Leu-240/Gln-241 residues
of the canonical MIU motif was equally active as wild-type
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Fig. 5 Determinants of chain specificity. a Recognition of ubiquitin C terminus by the catalytic core of ZUFSP. Ubiquitin (blue) and ZUFSP (gray/green)
shown in cartoon representation with key residues highlighted as sticks. Blue and black residue labels refer to ubiquitin and ZUFSP, respectively. Salt
bridges are indicated by dotted lines. b Activity of C-terminus recognition mutants (ZUFSP232–578 D406A or E428A) against K63-linked Ub4 was
compared to ZUFSP232–578 and inactive ZUFSP (ZUFSP232–578 C360A). c Activity of mutants described in b against RLRGG-AMC. The RFU values shown
are the means of triplicates. d Structural superposition of ubiquitin-binding interfaces to zUBD (cyan, this work) and the MIU domain of Rabex-5 (2FIF,
orange). Orientation of the two helical ubiquitin-binding domains differ by 20°. e SeqLogo45 representation of the consensus sequences for the MIU
motif14 (top) and the zUBD derived from the ZUFSP family as shown in Supplementary Fig. 1 (bottom). f Magnification of the interaction interface between
ubiquitin and zUBD. Relevant residues are shown as sticks and labeled black in case of ubiquitin and cyan in case of zUBD. Electrostatic interactions are
indicated as dotted lines. g Activity of a MIU mutant (ZUFSP148–578 L240A/Q241A) and two zUBD mutants (ZUFSP148–578E256A and E259A) on K63-
linked Ub4, in comparison to wild-type ZUFSP148-578. h Activity time course of the α2/3-deletion mutant ZUFSP148–578; Δ-α2/3 on K63-linked Ub4 chains,
compared to activity of the parental ZUFSP148–578 construct
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cleavage (Fig. 5g). The positioning of the α2/α3 hairpin protru-
sion is expected to contact the proximal (S1’) ubiquitin, which is
not part of the available structure. A ZUFSPΔ277-310 mutant
lacking this region showed a strongly reduced activity against
Ub4 chains (Fig. 5h), suggesting a contribution of the α2/α3
region to ubiquitin recognition. All mutants tested in Fig. 5g, h
remained fully active against the model substrate RLRGG-AMC
(Supplementary Fig. 2e, f), suggesting that the observed difference
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Fig. 6 ZUFSP localization and interaction network. a FLAG-tagged versions of inactive ZUFSPC360A (left) and active ZUFSP (middle, right) were expressed
in HEK293T cells and co-precipitating proteins quantified by mass spectrometry. Log2 enrichment ratios relative to uninduced/untransfected controls are
plotted against log10 signal intensity. The right panel shows the results after nuclease treatment. Consistently enriched proteins are labeled in color, red for
DNA-dependent and blue for DNA-independent enrichment. The bait ZUFSP is off-scale and hence not shown; the x/y coordinates are 9.7/11.1 (left), 11.0/
11.2 (middle), and 10.5/11.6 (right panel). b FLAG-tagged ZUFSP was immunoprecipitated from HEK293T cells in the presence or absence of nuclease.
Coimmunoprecipitated endogenous RPA32 was visualized with α-RPA32 4E4. c Electrophoretic mobility shift assay (EMSA) comparing the DNA-binding
preferences of the full-length ZUFSP to the N-terminal truncations (ZUFSP148–578 and ZUFSP232–578). All constructs were tested against a panel of
oligonucleotides previously tested for SSBP1 binding28, including ssDNA, dsDNA, short hairpin (OriL), and long hairpin (OriL+6). d Localization of ZUFSP
N-terminally fused to mVenus or C-terminal fused to eGFP (green) was visualized in fixed U2OS cells. Cells are shown in phase contrast (PhaCo) and
nuclei are stained with DAPI (blue). Scale bar= 10 µm. e Localization of mVenus-tagged ZUFSP to sites of NIR laser-induced DNA damage in U2OS cells
(top panels), as compared to eGFP alone (bottom panels). Images were taken immediately before (left) and 10 s after 800 nm laser irradiation (right).
Scale bar= 10 µm
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ZUFSP localization and interaction network. For getting
insights into the biological function of ZUFSP, cellular interactors
of this DUB were identified. To that end, FLAG-tagged full-length
ZUFSP was stably expressed in HEK293T cells under tetracycline
control. At 24 h after induction, the tagged ZUFSP construct was
immunopurified together with its binding partners and analyzed
by mass spectrometry. For comparison, a transiently transfected
C360A mutant was immunopurified and analyzed accordingly.
Relative to the uninduced and untransfected controls, both wild-
type and inactive ZUFSP co-purified with a nearly identical set of
highly enriched proteins, consisting of RPA1, RPA2, RPA3
(constituents of replication protein A (RPA)), SSBP1 (mito-
chondrial replication protein), the deubiquitinase USP11, the
ubiquitin ligase UBR5, ubiquitin itself, and the uncharacterized
protein TCEAL1 (Fig. 6a). Since the RPA proteins and SSBP1 are
known to bind single-stranded DNA (ssDNA), we tested the
interactions for DNA dependence by repeating the co-
purification in the presence of nuclease. After removal of DNA,
all four ssDNA binding proteins were no longer enriched, while
binding to USP11, TCEAL1, and ubiquitin was not affected. The
DNA-dependent binding of ZUFSP to the RPA complex was
confirmed by co-immunoprecipitation experiments. Full-length
ZUFSP expressed in HEK293T cells co-precipitated endogenous
RPA2, as visualized by an α-RPA32 antibody, while no RPA2 co-
precipitation was observed in the presence of nuclease (Fig. 6b).
To test whether ZUFSP is itself an ssDNA binding protein,
electrophoretic mobility shift assays (EMSAs) were performed.
Full-length ZUFSP was able to partially shift ssDNA, hairpin and
double-stranded DNA (dsDNA) oligonucleotides, while the
232–578 truncation was a better binder (Fig. 6c). The poor
binding of full-length ZUFSP and the preference for structures
containing dsDNA makes it unlikely that a direct ssDNA binding
accounts for the DNA-dependent interaction with RPA subunits
and SSBP1. Since available ZUFSP antibodies failed to stain
endogenous ZUFSP in immunofluorescence experiments, the
subcellular localization in U2OS cells was determined for ecto-
pically expressed ZUFSP fused to fluorescent proteins at either N
or C terminus. Both constructs showed a uniform distribution
throughout cytoplasm and nucleus (Fig. 6d). Two-photon near-
infrared (NIR) laser microirradiation of U2OS nuclei lead to a
partial and short-lived (<1 min) recruitment of ZUFSP to irra-
diated areas (Fig. 6e).
Discussion
The discovery that C6orf113/ZUFSP and its homologs form a
seventh class of deubiquitinating enzymes is interesting in several
respects, including DUB evolution, catalytic mechanism, and the
role of ubiquitin-binding domains in determining DUB specifi-
city. The existence of—so far—seven different DUB classes also
raises the question of how the different deubiquitination tasks are
distributed between the different classes.
In sequence databases, the previously uncharacterized protein
C6orf113 is referred to as ZUFSP (zinc finger with UFM1-specific
peptidase domain protein) because in the Pfam database19 its
sequence scores significantly against a Hidden Markov Model
(PF07910) describing the UFM1 proteases. However, depending
on the exact sequence search method and parameters, the ZUFSP
family appears to be nearly equidistant to the UFSP and ATG4
families, with a distance resembling that between UFSP and
ATG4 (Supplementary Fig. 6). Thus, ZUFSP is clearly not a
member of the UFSP family, but rather forms a superfamily with
the processing enzymes for UFM1 and Atg8/Atg12. Both UFM1
and Atg8/Atg12 are extremely divergent members of the
ubiquitin-like modifier family with no overt sequence similarity
to ubiquitin. Unlike the canonical 'GG' motif found at the C
terminus of most ubiquitin-like modifiers, UFM1 and Atg8/Atg12
have only the second glycine residue conserved. Considering the
high divergence between the three modifier types, it was sur-
prising that one superfamily member is a linkage-specific endo-
cleaving ubiquitin isopeptidase. A possible explanation for the
substrate switch might be the different active site geometry, in
combination with the presence of multiple UBDs that determine
cleavage specificity within the ZUFSP/Mug105 family.
In evolutionary terms, the ZUFSP family is rather ancient, with
recognizable members from all eukaryotic kingdoms. However,
the phyletic distribution is characterized by many independent
gene loss events, suggesting that ZUFSP function is either not
universally required or that another DUB has been co-opted in
certain lineages. ZUFSP family members are widespread in ani-
mals, plants, and fungi; they are also found in several other taxa,
including Cryptophyta, Alveolata, Amoebozoa, and Rhizaria.
Gene loss events affect many common model organisms: unlike
some other nematodes, Caenorhabditis elegans lacks a ZUFSP-
like protein; the same is true for the insect model Drosophila
melanogaster and the budding yeast Saccharomyces cerevisiae,
which both lack this DUB despite clear ZUFSP homologs being
present in other Dipterans and Ascomycetes. This heterogeneity is
also seen in the surprisingly diverse domain architectures of
ZUFSP family members. All family members share the conserved
catalytic domain anchored to the C terminus. Several protists
have minimalistic proteins resembling Mug105, while the N-
terminal regions of most taxa contain at least one ubiquitin-
binding domain. Recurring architectures include 1xUBZ (most
plants), 2xUBZ (most ascomycete fungi), 5xUBZ and 1xzUBD
(insects), or 3xMIU but no zinc fingers in several alveolates
(Supplementary Fig. 7). The UFSP proteases have also been lost
in many lineages, together with the entire UFM1-modification
system, but there is little correspondence to the species lacking
ZUFSP family proteases. The absence of UFM1 and UFSPs from
the yeast S. pombe underscores once more that Mug105 has no
connection to UFM1 signaling. Despite their overall similarity in
structure and sequence, ZUFSP proteases use an active site his-
tidine residue different from that used in the UFSP and ATG4
families. Apart from the active site residues, all three families
show a structural fold similar to the papain-type proteases, a fold
that is also used by most other DUBs and UBL proteases20. In
fact, the active site arrangement of ZUFSP, with the catalytic
histidine upstream of the catalytic aspartate (C-H-D), is typical of
papain fold proteases including USP-type deubiquitinases. It is
therefore likely that the UFSP and ATG4 families evolved from a
ZUFSP-like ancestor, and that the C-D-H active site of the two
UBL-protease families is a derived feature.
The globular portion of ZUFSP, which is resolved in the
covalent complex structure, has two regions of contact with the
distal (S1) ubiquitin, which—at least partially—explains the spe-
cificity for K63-linked ubiquitin chains. The recognition of the
two Arg residues in the ubiquitin C terminus through salt bridges
is not unusual for DUBs. A similar arrangement can be seen in
the substrate complex of USP21 and other USP-type deubiqui-
tinases21. The resulting interactions position the ubiquitin C
terminus favorably relative to the active site and should help in
the recognition of the sequence R-x-R-G-G. Since mutating only
one of the two acidic recognition counterparts is sufficient to
abrogate the activity, recognition of both C-terminal arginine
residues is required. Accordingly, the peptide-based model sub-
strate RLRGG-AMC is cleaved very effectively, while NEDD8
(ending on ALRGG), SUMO1 (EQTGG), and SUMO2 (QQTGG)
are not processed. However, ISG15 also ends on RLRGG but is
not recognized by ZUFSP, showing that a second recognition
layer must be in place. Contact site analysis suggests that the
binding of the newly defined zUBD domain to the Ile-44-patch of
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the S1 ubiquitin is responsible for the second recognition event,
most likely enhanced by binding of the adjacent MIU domain to
the S2-ubiquitin, which is not part of the structure. The zUBD
domain binds ubiquitin in an approximately MIU-like manner,
albeit with a different angle and a different consensus sequence
for the contacting residues. The combination of zUBD and MIU
on a contiguous helix forms a suitable surface for the recognition
of K63 linkages, analogous to the recognition of K63 chains by the
tandem-UIM domains of Rap8022. The available structure does
not reveal how this second binding interface excludes ISG15, a
ubiquitin fold with the proper RLRGG C terminus but without
Ile-44 patch, from being cleaved by ZUFSP. One attractive model
would posit that in the absence of ubiquitin, the α1-helix would
fold back and obstruct access to the active site—at least for
substrates larger than the RLRGG-AMC pentapeptide. On the
other hand, the α1-deficient ZUFSP274–578 variant is severely
defective for ubiquitin chain cleavage, suggesting that the zUBD/
MIU binding to the Ile-44 patch, together with hydrogen bonds
formed by the ubiquitin-specific Arg-42 residue (Fig. 5a), might
just be a necessary contribution to the overall substrate affinity.
Particularly intriguing is the different linkage specificity of
human ZUFSP and its S. pombe homolog Mug105. While in
ZUFSP, the K63 specificity can be largely rationalized by the rigid
positioning of recognizable UBDs relative to the active site, the
lack of a Mug105 crystal structure precludes the identification of
the S1 and S1’ sites required for K48 specificity. Since Mug105 is a
radically reduced version of the ZUFSP architecture, it is safe to
assume that the substrate recognition sites of Mug105 are found
on surfaces that are not accessible in the human ZUFSP protein.
A truncation of human ZUFSP310-578, down to the core peptidase
domain as found in Mug105, did not recapitulate the shift to
K48 specificity, but rather abrogated chain cleavage altogether.
Apparently, the surface required for K48 recognition is not
conserved in the human protein. While the maximally shortened
ZUFSP310–578 no longer cleaved ubiquitin chains, it was still
active against ubiquitin-AMC and RLRGG-AMC, showing that
the truncated protein is properly folded and has maintained a
functional active site. In summary, human ZUFSP has a unique
modular architecture, consisting of a catalytic core made for
cleaving after R-x-R-G-G motifs, but not able to efficiently recruit
ubiquitin chains to the active site. The necessary capability for
ubiquitin recruitment and linkage specificity is conferred to the
core domain by a number of ubiquitin-binding domains, such as
the rigidly linked zUBD and MIU, as well as the flexibly linked
UBZ-like domains. It will be interesting to study if the various
UBD classes linked to the catalytic core of other ZUFSP family
members might confer yet different linkage specificities.
Despite their different domain architecture, human ZUFSP and
S. pombe Mug105 appear to be orthologs, although it cannot be
formally ruled out that both metazoan and fungal lineages have
experienced gene losses of the true orthologs, leaving ZUFSP and
Mug105 as pseudo-orthologs23. In either case, the difference in
linkage specificity implies that ZUFSP and Mug105 have either
assumed different biological roles or work in a biological path-
way, which in humans and S. pombe is governed by different
chain types. Neither ZUFSP nor Mug105 are functionally char-
acterized. The only fact reported about Mug105 is its transcrip-
tional upregulation during meiosis24, which is not informative
since several other meiotically upregulated genes in S. pombe are
involved in pathways without obvious connections to meiosis.
Our interaction studies in HEK293T cells found the three
subunits of RPA as the most enriched interactors, along with the
mitochondrial ssDNA binding protein SSBP1. This interaction is
corroborated by a recently reported incidental finding of ZUFSP
in a screen for RPA interactors25. The co-precipitation of endo-
genous RPA with ectopically expressed ZUFSP further supports
the authenticity of this interaction. RPA and SSBP1 are known to
perform analogous roles during replication and homologous
recombination in the nucleus and mitochondria, respectively.
During meiotic recombination and recombination repair, the two
factors perform a similar role in stabilizing the ssDNA of the
displacement loop (D-loop), which arises during strand inva-
sion26,27. Due to their different localization, it is unlikely that
RPA and SSBP1 form a complex, suggesting that ZUFSP recog-
nizes these two similar factors independently. Both SSBP1 and
RPA1 are known to bind ssDNA, which raises the question of
whether their interaction with ZUFSP is direct or possibly
bridged by ssDNA. Indeed, when repeating the interaction
experiment in the presence of a non-specific bacterial nuclease,
the enrichment of SSBP1 or RPA components was lost, while
other interaction partners such as USP11 and TCEAL1 were not
affected. These findings suggest that ZUFSP either recognizes a
nucleic acid containing complex of RPA and SSBP1 or that
ZUFSP itself is a DNA-binding protein. As seen in the EMSA
experiments, ZUFSPs do in fact bind to DNA, but several
observations make it unlikely that ZUFSP DNA-binding prop-
erties can explain the DNA-dependent association to RPA and
SSBP1. When comparing the DNA-binding profile of ZUFSP to
that of SSBP1 using the same set of oligonucleotides28, it becomes
apparent that full-length ZUFSP binds DNA rather poorly and
prefers dsDNA-containing binding partners over pure ssDNA
partners. By contrast, SSBP1 does not bind to dsDNA and prefers
the ssDNA oligonucleotide over those containing hairpin struc-
tures28. Thus, a more complex recognition mode of the replica-
tion and recombination factors RPA and SSBP1 has to be
assumed.
Summing up, the highly reproducible and DNA-dependent
interaction of ZUFSP with nuclear and mitochondrial replication
factors suggests a role of this DUB class in the regulation of
replication and/or homologous recombination. This idea is
compatible with the presence of ZUFSP in the nucleus and its
transient recruitment to NIR-induced DNA damage sites. The
biochemical properties of ZUFSP suggest that it generally targets
K63 chains, rather than particular substrates, after being recruited
to its site of action by one or more of its interaction partners.
Ubiquitination by K63-linked chains are a hallmark of several
DNA damage pathways29,30. While the processes activating the
damage-responsive ubiquitin ligases are reasonably well under-
stood, the removal of K63 chains during or after resolution of the
damage is more enigmatic. The discovery of ZUFSP as a K63-
DUB, making DNA-mediated interactions with RPA and SSBP1,
will be instrumental for addressing these important questions.
Methods
Constructs and cloning. ZUFSP was cloned from HEK293 complementary DNA
and Mug105 from S. pombe genomic DNA (kind gift from J. Dohmen, University
of Cologne) using Phusion DNA Polymerase (New England Biolabs). For protein
purification, all constructs were cloned in the pOPIN-S vector31 using the In-
Fusion® HD cloning system (Takara Clontech). Point mutations were generated
using the QuikChange Lightning kit (Agilent Technologies). For the generation of
the stable cell line full-length ZUFSP was cloned into the pCDNA5/FRT/TO vector
(ThermoFisher). ZUFSP was cloned into popinE-3C-eGFP (kind gift from Ray
Owens, OPPF UK) and pCL-Neo-mVENUS (gift from Niels Gehring, University of
Cologne) for localization studies. Constructs for ubiquitin-PA purification
(pTXB1-ubiquitin1–75) and pOPIN-S USP21196-565 were a kind gift of D.
Komander (MRC LMB Cambridge).
Protein purification. Full-length ZUFSP, all truncations and mutants, and Mug105
were expressed from pOPIN-S vector with an N-terminal 6His-Smt3-tag. All
constructs were transformed into Escherichia coli (Strain: Rosetta (DE3)pLysS).
Then, 6–12 l cultures were grown in LB media at 37 °C until the OD600 of 0.8 was
reached. The cultures were cooled down to 18 °C and protein expression was
induced by addition of 0.2 mM isopropyl β-D-1-thiogalactopyranoside (IPTG). For
full-length ZUFSP and ZUFSP148-578 constructs, 0.1 mM ZnSO4 was added in
addition to the IPTG. After 16 h, the cultures were harvested by centrifugation at
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5000 × g for 15 min. After freeze thaw, the pellets were resuspended in binding
buffer (300 mM NaCl, 20 mM TRIS pH 7, 20 mM imidazole, 2 mM β-mercap-
toethanol) containing DNase and Lysozyme, and lysed by sonication. Lysates were
clarified by centrifugation at 50,000 × g for 1 h at 4 °C and supernatant was used for
affinity purification on HisTrap FF columns (GE Healthcare) according to the
manufacturer's instructions. For all constructs, except the ones used for pull-down
analysis, the 6His-Smt3 tag was removed by incubation with Senp1415-644 and
concurrent dialysis in binding buffer. The liberated affinity-tag and Senp1 were
removed by a second round of affinity purification with HisTrap FF columns (GE
Healthcare). If necessary, proteins were further purified by anion exchange chro-
matography (HiScreen Q HP, GE Healthcare) or cation exchange chromatography
(HiScreen SP HP, GE Healthcare). All proteins were finally subjected to size
exclusion chromatography (HiLoad 16/600 Superdex 75 or 200 pg) in 20 mM TRIS
pH 7, 150 mM NaCl, 2 mM dithiothreitol (DTT), concentrated using VIVASPIN
20 Columns (Sartorius), flash frozen in liquid nitrogen, and stored at −80 °C.
MBP-Ufsp2 was expressed and purified as described previously32. In brief,
MBP-Ufsp2 was expressed as indicated above. Bacteria were lysed in binding buffer
(20 mM TRIS pH 7.5, 200 mM NaCl, 2 mM DTT) and the supernatant was used
for affinity purification on a MBPTrap (GE Healthcare). MBP-Ufsp2 was eluted
with binding buffer containing 10 mM maltose, subjected to size exclusion
chromatography (HiLoad 16/600 Superdex 200 pg; GE Healthcare) in 20 mM TRIS
pH 7.5, 150 mM NaCl, 2 mM DTT, concentrated using VIVASPIN 20 Columns
(Sartorius), flash frozen in liquid nitrogen, and stored at −80 °C.
AMC activity assays. Activity assays of DUBs against AMC-labeled Ub/UbL
substrates were performed using reaction buffer (150 mM NaCl, 20 mM TRIS pH
7, 10 mM DTT) 1 µM DUBs and 10 µM zRLRGG-AMC (BACHEM AG, Swit-
zerland), 1 µM Sumo1-AMC, 1 µM Sumo2-AMC (Boston Biochem, Inc., USA), 1
µM ISG15-AMC (Boston Biochem, Inc., USA), 1 µM Nedd8-AMC (ENZO Life
Sciences GmbH, Germany), LC3A-AMC (Boston Biochem, Inc., USA), or 5 µM
Ub-AMC (UbiQ-Bio, The Netherlands). The reaction was performed in black 96-
well plates (Corning) at 30 °C and released fluorescence was measured using the
Infinite F200 Pro plate reader (Tecan) equipped for excitation wavelength of 360
nm and an emission wavelength of 465 nm. The measurements were performed in
triplicate and the mean is presented.
Kinetics. For determination of the specific activity against Ub-AMC the initial
velocity was determined from a measurement of 100 nM DUB against 5 µM Ub-
AMC in reaction buffer (150 mM NaCl, 20 mM TRIS pH 7, 10 mM DTT). Steady-
state kinetics of ZUFSP or Mug105 against RLRGG-AMC were measured in
reactions containing 100 nM DUB and the indicated concentrations of RLRGG-
AMC in reaction buffer. Measurements were performed at 30 °C in triplicate.
Initial velocities were plotted against the RLRGG-AMC concentrations and fitted to
the Michaelis–Menten equation using Prism 6 (GraphPad) software.
Ub and LC3B-PA synthesis. The constructs pTXB1-ubiquitin1–75 pTXB1-
LC3B1–119 were used to express ubiquitin or LC3B as a C-terminal intein fusion
protein as described in ref. 33. In brief, the fusion protein was affinity purified in
buffer A (20 mM Hepes, 50 mM sodium acetate, pH 6.5, 75 mM NaCl) from
clarified lysates using Chitin Resin (New England Biolabs) following the manu-
facturer's protocol. On-bead cleavage was performed by incubation with cleavage
buffer (buffer A containing 100 mM MesNa (sodium 2-mercaptoethanesulfonate))
for 24 h at room temperature (RT). Resin was washed extensively with buffer A and
pooled fractions were concentrated and subjected to size exclusion chromato-
graphy (HiLoad 16/600 Superdex 75) with buffer A. To synthesize Ub/LC3B-PA,
300 µM Ub/LC3B-MesNa were reacted with 600 µM propargylamine hydro-
chloride (Sigma Aldrich) in buffer A containing 150 mM NaOH for 3 h at RT.
Unreacted propargylamine was removed by size exclusion chromatography and
Ub/LC3B-PA was concentrated using VIVASPIN 20 Columns (3 kDa cutoff,
Sartorius) flash frozen and stored at −80 °C.
Rho-UFM1-PA synthesis. UFM1 was synthesized by total linear solid-phase
peptide synthesis (SPPS) on a Syro II MultiSyntech Automated Peptide synthesizer
using standard 9-fluorenylmethoxycarbonyl (Fmoc) based solid-phase peptide
chemistry at a 40 μmol scale, using fourfold excess of amino acids relative to pre‐
loaded Fmoc amino acid trityl resin (0.2 mmol/g, Rapp Polymere GmbH). Peptide
couplings were performed using benzotriazol-1-yl-oxytripyrrolidinophosphonium
hexafluorophosphate (PyBOP, 4 equivalent (equiv)) and N,N-diisopropylethyla-
mine (DiPEA, 8 equiv) in N-methyl-2-pyrrolidone (NMP) for 45 min. Fmoc
removal was executed using 20% piperidine in NMP for 2 × 2 and 1 × 5min. 5-
Carboxy-Rhodamine-110 was coupled to the N terminus of resin-bound UFM1
and subsequently the fluorescently labeled UFM1 was cleaved off the resin using
hexafluoroisopropanol (HFIP) in dichloromethane (DCM) (1:4 v/v) for 2 times for
20 min and filtered, thereby only liberating the C-terminal carboxylic acid while
leaving all other protective groups in place. The flow-through was collected and
concentrated in vacuo, followed by coevaporation with dichloroethane (3×) to
remove residual HFIP. Subsequently, the protected peptide was dissolved in DCM
and reacted with PyBOP (5 equiv), DiPEA (15 equiv), and propargylamine (15
equiv) for 16 h. The reaction was concentrated in vacuo and treated with 90.5%
trifluoroacetic acid, 5% water, 2.5% phenol, and 2% tri-isopropylsilane for 2.5 h to
globally remove all protective groups. The fully deprotected peptide was pre-
cipitated from Et2O/Pentane (1:1, v/v) and subsequently redissolved in dimethyl
sulfoxide/water (1:9, v/v) and purified using reverse-phase high-performance liquid
chromatography. Lyophilisation of the appropriate fractions yielded the target
activity-based probe, which was analyzed by liquid chromatography–mass spec-
trometry (LC-MS; Waters 2795 Separation Module (Alliance HT), Waters 2996
Photodiode Array Detector (190–750 nm), Phenomenex Kinetex C18 (2.1 × 100,
2.6 μm) column, and LCTTM orthogonal acceleration time of flight mass
spectrometer.
Suicide probe assay. DUBs were prediluted to 2× concentration (10 µM) in
reaction buffer (20 mM TRIS pH 7, 150 mM NaCl and 10 mM DTT) and 1:1
combined with 100 µM Ub-PA, LC3B-PA, 2K48-VME (UbiQ-Bio), or 2K63-VME
(UbiQ-Bio). After 16 h of incubation at 4 °C, the reaction was stopped by addition
of Laemmli buffer, resolved by sodium dodecyl sulfate–polyacrylamide gel elec-
trophoresis (SDS-PAGE), and Coomassie stained. For demonstrating Ub specificity
of ZUFSP, full-length ZUFSP was incubated with either Cy5-Ub-Propargylamine15
(Cy5-Ub-PA) (10 µM) or Rho-UFM1-Propargylamine (Rho-Ufm-PA) (10 µM) in
50 mM Tris-HCl pH 7.5, 100 mM NaCl, and 2 mM DTT at 37 °C for 30 min.
The reaction was quenched by the addition of reducing sample buffer and heating
at 95 °C for 3 min. Samples were resolved by SDS-PAGE and labeled enzymes were
visualized by in-gel fluorescence scanning using the Typhoon FLA imaging system
(GE Healthcare Life Sciences) (λex/ λem= 625/ 680 nm and λex/ λem= 480/ 530
nm) and subsequent silver staining.
Chain generation. Met1-linked di-ubiquitin was expressed as a linear fusion
protein and purified by ion exchange chromatography and size exclusion chro-
matography. K11-, K48-, and K63-linked ubiquitin were enzymatically assembled
using UBE2SΔC (K11), CDC34 (K48), and Ubc13/UBE2V1 (K63) as previously
described34,35. In brief, ubiquitin chains were generated by incubation of 1 µM E1,
25 µM of the respective E2 and 2 mM ubiquitin in reaction buffer (10 mM ATP, 40
mM TRIS (pH 7.5), 10 mM MgCl2, 1 mM DTT) for 18 h at RT. The reaction was
stopped by 20-fold dilution in 50 mM sodium acetate (pH 4.5) and chains of
different lengths were separated by cation exchange using a Resource S column (GE
Healthcare). Elution of different chain lengths was achieved with a gradient from 0
to 600 mM NaCl.
Chain cleavage assays. DUBs were preincubated in 150 mM NaCl, 20 mM TRIS
pH 7, and 10 mM DTT for 10 min. The cleavage was performed for the indicated
time points with 5 µM DUBs and either 25 µM di-ubiquitin (K11, K63, and
K48 synthesized as described above, others from Boston Biochem) or 5 µM tetra-
ubiquitin (Boston Biochem) at RT, stopped with Laemmli buffer, resolved by SDS-
PAGE, and Coomassie stained.
Crystallization. 100 µM ZUFSP232-578 was incubated with 200 µM ubiquitin-PA
for 18 h at 4 °C. Unreacted ZUFSP and Ub-PA were removed by size exclusion
chromatography. The covalent ZUFSP232-578 and Ub-PA complex (12 mg/ml) was
crystallized using the vapor diffusion sitting drop method. Crystallization trials
were set up with drop ratios of 1:2, 1:1, 2:1 protein solution to precipitant solution
with a total volume of 300 nl. Initial crystals appeared in PEG/Ion (Hampton
Research) E4 (0.2 M sodium malonate pH 5, 20% polyethylene glycol 3350 (PEG
3350)) after 2 days at 4 °C. Optimization was carried out with 3 µl drops (protein/
precipitant ratios: 2:1, 1:1 and 1:2) and precipitant solutions varying in pH or PEG
3350 concentration respectively. Best crystals were obtained from the crystal-
lization trial where protein solution was mixed 1:1 with precipitant solution
composed of 0.2 M sodium malonate pH 5, 20% PEG 3350. Crystals were flash-
cooled in reservoir solution containing 20 % (v/v) glycerol.
Data collection, phasing, model building, and refinement. Diffraction data were
collected at beamline P13 at EMBL Hamburg, Deutsches Elektronen-Synchrotron
(DESY), Hamburg, Germany, and processed using X-ray detector software (XDS)36.
For S-SAD (single-wavelength anomalous dispersion of S atoms) phasing, a highly
redundant dataset at 2.06 Å was collected at 6 different κ-angles with a 360° sweep
each, and subsequently initial phases were determined using the autosol.phenix
routine37. Afterwards, the model was built manually in Coot and with autobuilt.
phenix38,39. Iterative cycles of refinement between building steps were performed with
phenix.refine40 using the high-resolution dataset (1.7 Å) recorded at a wavelength of
0.97 Å. Restrains of the propargyl moiety were calculated using phenix.elbow41.
Ubiquitin-binding assay. A total of 20 µl Nickel resin (MagneHis™ Protein Pur-
ification System, Promega) was saturated with 6His-Smt3 tagged ZUFSP trunca-
tions in 200 µl binding buffer (20 mM TRIS pH 7.5, 150 mM NaCl, 20 mM
imidazole and 0.1% NP-40) and incubated for 1 h at 4 °C. All truncations con-
taining the catalytic domain were inactivated by a C360A mutation. The resin was
washed three times with binding buffer and afterwards incubated with the twofold
molar excess of K63-linked ubiquitin chains for 2 h at 4 °C. The washing steps were
repeated and the protein was eluted from the beads by addition of 30 µl Laemmli
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buffer. The proteins were separated via SDS-PAGE and the subsequent western
blots were visualized with α-Smt3 (1:10000; kind gift of J. Dohmen, University of
Cologne) or α-ubiquitin P4D1 antibody (1:5000; 3936S; Cell Signaling Technol-
ogy), respectively.
Cell culture, transfection, and stable cell line generation. HEK293T (ATCC®
CRL-3216™), HEK293 Flp-In T-REx (ThermoFisher Scientific), and U20s (ATCC®
HTB-96™) were maintained by serial passage in Dulbecco’s modified Eagle's
medium, high glucose (Invitrogen Life Technologies) supplemented with 2 mM of
L-glutamine, 1 mM of sodium pyruvate, 1× minimal essential medium non-
essential amino acids, 100 U/ml of penicillin, 100 µg/ml of streptomycin (PAA),
and 10% fetal calf serum (Biochrom). The stable 3xFLAG-ZUFSP cell line was
generated by co-transfection of HEK293 Flp-In T-Rex with pCDNA5 /FRT/TO
3xFLAG-ZUFSP and pOG44 vectors followed by selection with 0.1 mg/ml
Hygromycin B (Sigma Aldrich). Single colonies were picked and expression of
3×FLAG-ZUFSP was induced by incubation with 1 µg/ml tetracycline for 24 h.
Expression of 3xFLAG-ZUFSP was tested by western blot with α-FLAG M2
antibody (1:3000; F1804; Sigma Aldrich). Transfections for the generation of stable
cell lines or transient expression were performed using TransIT-LT1 (Mirus Bio)
according to the manufacturer's protocol.
Immunofluorescence microscopy and laser-induced DNA damage. For locali-
zation studies, U2OS cells on coverslips were fixed with 3% paraformaldehyde 24 h
after transfection with the respective constructs. Fixed cells were permeabilized
with 0.1% Saponin in 1× phosphate-buffered saline and stained with DAPI (4′,6-
diamidine-2′-phenylindole dihydrochloride; Sigma Aldrich) for 15 min. Subse-
quently, cells were mounted on slides using ProLong Gold antifade reagent and
analyzed. Fluorescence images were obtained and processed using a LMS 710
confocal scanning laser microscopy system (Zeiss). For NIR laser irradiation for
inducing DNA damage, a Leica TCS SP8 MP-OPO confocal scanning laser
microscope was used at the excitation wavelength of 488 nm and a wavelength of
800 nm for inducing the DNA damage. U2OS Cells were seeded in glass-bottomed
dishes 35 mm (Ibidi) 2 days before the experiments and transfected with the
enhanced green fluorescent protein (eGFP)/mVenus expression vectors 1 day
before the DNA damage experiments. Time series of 2 to 3 min were performed by
taking a picture every 10 s.
Purification and MS analysis of interacting proteins. Flp-In T-REx 293 cells or
Flp-in T-REx 293 cells with stable 3xFLAG-ZUFSP integration were seeded in 10 cm
dishes and protein expression was induced by addition of 1 µg/ml tetracycline.
Alternatively, HEK293T cells were transiently transfected with pCMV2b 3xFLAG-
ZUFSP using TransIT-LT1 transfection reagent. At 24 h after induction or transfec-
tion, cells were harvested and lysed in lysis buffer (20mM TRIS pH 7, 150mM NaCl,
0.1% NP-40, complete protease inhibitor (Roche)) for 30min at
4 °C, and briefly sonicated before centrifugation at 13,000 × g for 10min. The
supernatant was incubated with prewashed magnetic anti-FLAG M2 beads (Sigma
Aldrich) for 2 h at 4 °C. Beads were washed three times with lysis buffer for 5min.
Last washing step was performed with lysis buffer without NP-40. For western blot
analysis with rabbit α-FLAG (1:3000; F7425, Sigma Aldrich) and rat α-RPA32 (4E4)
(1:1000; 2208S; Cell Signaling Technology) proteins were eluted by addition of 2×
Laemmli buffer. For MS analysis, bound proteins were eluted with 200 µg/ml 3xFLAG
peptide (Sigma Aldrich) in 6M urea, 2M thiourea. Eluted proteins were prepared for
mass spectrometry by incubation with 1mM DTT for 1 h, 55mM iodoacetamide for
45min, 0.005 ng/µl Lys-C for 2 h and 0.005 ng/µl Trypsin for 18 h. For LC-MS/MS
analysis, an EASY-nLC 1000 chromatograph (Thermo Scientific) was coupled to the
quadrupole-based Q Exactive Plus (Thermo Scientific) instrument by a nano-spray
ionization source. Peptides were separated on a 50 cm in-house-packed column using
a two-solvent buffer system: buffer A (0.1% formic acid) and B (0.1% formic acid in
acetonitrile). The amount of buffer B was increased from 7% to 23% within 40min,
followed by an increase to 45% in 5min, and a washing and re-equilibration step
before the next sample injection. The mass spectrometer operated in a Top 10 data-
dependent mode, using the following settings: MS1: 70,000 (at 200m/z) resolution,
3e6 AGC target, 20 ms maximum injection time, 300–1750 scan range; MS2: 35,000
(at 200m/z) resolution, 5e5 AGC target, 120ms maximum injection time, 1.8 Th
isolation window, 25 normalized collision energy. Data analysis was performed by
MaxQuant software, V 1.5.4.742 using the Andromeda search engine43 against the
human proteome reference data (including splice variants) from Uniprot. Default
mass tolerance and modification settings were used. Re-quantify, label-free quantifi-
cation, and match between runs were enabled. ‘Oxidation on M’, ‘Phosphorylation on
S,T,Y’, and ‘GlyGly on K’ were allowed as variable modifications. Intensities were
averaged over biological triplicates, and the log2 of the intensity ratio ‘sample average/
control average’ was used for enrichment quantification. To account for missing
values, pseudocounts corresponding to the minimal observed intensity were added to
sample and control averages.
Electrophoretic mobility shift. The EMSA assays were carried out as previously
described44 using oligonucleotides described previously to bind SSBP128. In brief,
0.5 µM of ssDNA (5′-GGGCTTCTCCCGCCTTTTTTCCCGGCGGCGGGAGA
AGTAGATTGAAG-3′), labeled at the 5′-end with 6-Fam, was incubated with 5
µM of the respective ZUFSP truncation in 40 µl reaction buffer (10 mM TRIS pH
7.5, 0.2 mM DTT, 5 µM ZnSO4) for 1 h at 4 °C. The DNA-protein complexes were
run on an 1.5% agarose gel and visualized by a ChemiDoc MP imaging system
(BioRad). The dsDNA was created by annealing the 6-Fam labeled ssDNA with a






were annealed and used as described above. Gels were stained by SybrGold
(NEB) and analyzed on the ChemiDoc system.
Data availability. The structure of ZUFSP232-578 in covalent complex with Ub-PA
has been deposited in the Protein Data Bank under the accession code 6EI1. The
mass spectrometry data have been deposited to the ProteomeXchange Consortium
via the PRIDE partner repository (https://www.ebi.ac.uk/pride) under the accession
code PXD008731. All other data supporting the presented findings are available
from the corresponding author upon request.
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